Drug Chatter -- Tracking biopharma stock chatter

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@RNAiAnalyst 27
@bansisharma 19
@YuZhu4 15
@CFinancialNews 13
@SleekMoneycom 13

Recent Tweets for ALNY

SleekMoneycom @SleekMoneycom
Alnylam Pharmaceuticals, Inc. $ALNY Given “Overweight” Rating at Barclays PLC https://t.co/fcGR0OAYkv
September 23rd 2017, 11:09pm
BioPharmaDive @BioPharmaDive
Success in the study puts $ALNY in position to win the first approval of a drug based on RNA interference https://t.co/xLUWNemJsT
September 23rd 2017, 1:09pm
ChartMill @ChartMill
Like it or not, but $ALNY's techical report is impressive https://t.co/kHivcaV7ij
September 23rd 2017, 1:09pm
WatchlistN @WatchlistN
Alnylam Pharmaceuticals’ $ALNY “Outperform” Rating Reaffirmed at BMO Capital Markets https://t.co/N86ioAXZQK
September 23rd 2017, 1:09pm
WatchlistN @WatchlistN
ARK Investment Management LLC Lowers Stake in Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/CWj9nARiwF
September 23rd 2017, 12:09pm
WKRBNews @WKRBNews
Alnylam Pharmaceuticals, Inc. $ALNY Position Lifted by Van ECK Associates Corp https://t.co/9v5FpmFsBV
September 23rd 2017, 11:09am
dailypoliticaln @dailypoliticaln
Alnylam Pharmaceuticals, Inc. $ALNY Position Lifted by Van ECK Associates Corp https://t.co/ZnSW5fTDJb
September 23rd 2017, 11:09am
dailymailtimes @dailymailtimes
Alnylam Pharmaceuticals, Inc. $ALNY Position Lifted by Van ECK Associates Corp https://t.co/pGakS83cUm
September 23rd 2017, 11:09am
midetimes @midetimes
Alnylam Pharmaceuticals, Inc. $ALNY Position Lifted by Van ECK Associates Corp https://t.co/GoIwVkMtAF
September 23rd 2017, 11:09am
SPNewsAnalysis @SPNewsAnalysis
Alnylam Pharmaceuticals, Inc. $ALNY Earns “Hold” Rating from Stifel Nicolaus https://t.co/345dOJQWH7
September 23rd 2017, 11:09am
TheMarketsDaily @TheMarketsDaily
Alnylam Pharmaceuticals, Inc. $ALNY Price Target Raised to $128.00 https://t.co/MC3LXNGexd
September 23rd 2017, 11:09am
dakotafinancial @dakotafinancial
Needham & Company LLC Boosts Alnylam Pharmaceuticals, Inc. $ALNY Price Target to $125.00 https://t.co/zWvZJgvA57
September 23rd 2017, 10:09am
PariBayat @PariBayat
RT @docrodwong: congrats to $ALNY and TTR patients. Also a terrific day for #RNAi, #patisiran joins #spinraza saving lives. https://t.co/…
September 23rd 2017, 10:09am
NewsToDesk @NewsToDesk
$MDGL $ALNY: 3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?: https://t.co/MoYEsTrfqa
September 23rd 2017, 10:09am
dakotafinancial @dakotafinancial
Alnylam Pharmaceuticals, Inc. $ALNY Shares Bought by Fmr LLC https://t.co/yMUYTHJIfB
September 23rd 2017, 9:09am
emq_news @emq_news
Alnylam Pharmaceuticals, Inc. $ALNY Stock Rating Reaffirmed by Sanford C. Bernstein https://t.co/MROByylkzh
September 23rd 2017, 8:09am
TickerReport @TickerReport
Alnylam Pharmaceuticals, Inc. $ALNY Stock Rating Reaffirmed by Sanford C. Bernstein https://t.co/exdtdq31go
September 23rd 2017, 8:09am
TickerReport @TickerReport
Alnylam Pharmaceuticals, Inc. $ALNY Stock Rating Reaffirmed by Sanford C. Bernstein https://t.co/712g1MwpMi
September 23rd 2017, 8:09am
dailypoliticaln @dailypoliticaln
Wells Fargo & Company MN Sells 171,910 Shares of Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/f4KqXRcLIw
September 23rd 2017, 6:09am
dailymailtimes @dailymailtimes
Wells Fargo & Company MN Sells 171,910 Shares of Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/RDI1RHdcJp
September 23rd 2017, 6:09am
WKRBNews @WKRBNews
Wells Fargo & Company MN Sells 171,910 Shares of Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/BTKogHy68c
September 23rd 2017, 6:09am
midetimes @midetimes
Wells Fargo & Company MN Sells 171,910 Shares of Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/2qorAOaPkj
September 23rd 2017, 6:09am
SleekMoneycom @SleekMoneycom
Alnylam Pharmaceuticals, Inc. $ALNY Receives Buy Rating from Needham & Company LLC https://t.co/CLllWF9cSQ
September 23rd 2017, 6:09am
SPNewsAnalysis @SPNewsAnalysis
Alnylam Pharmaceuticals, Inc. $ALNY Position Maintained by Schroder Investment Management Group https://t.co/zDnHQSLxoc
September 23rd 2017, 6:09am
storminvestor @storminvestor
Alnylam Pharmaceuticals, Inc. $ALNY Position Maintained by Schroder Investment Management Group https://t.co/VeYHJWob3k
September 23rd 2017, 6:09am
ainekoVFX @ainekoVFX
RT @ChartMill: $ALNY showing the best technicals its sector https://t.co/4u3krWxyu7 #ue4 #BloombergGBF
September 23rd 2017, 6:09am
ChartMill @ChartMill
$ALNY showing the best technicals its sector https://t.co/4u3krWxyu7 #ue4 #BloombergGBF
September 23rd 2017, 5:09am
IRAMarketReport @IRAMarketReport
Alnylam Pharmaceuticals, Inc. $ALNY Holdings Boosted by Legal & General Group Plc https://t.co/TQsvBoMEji
September 23rd 2017, 4:09am
chaffeybreeze @chaffeybreeze
Alnylam Pharmaceuticals, Inc. $ALNY Holdings Boosted by Legal & General Group Plc https://t.co/tqTcRRH5NT
September 23rd 2017, 4:09am
TickerReport @TickerReport
Alnylam Pharmaceuticals Target of Unusually Large Options Trading $ALNY https://t.co/UFwrNyHisS
September 23rd 2017, 4:09am
TickerReport @TickerReport
Alnylam Pharmaceuticals Target of Unusually Large Options Trading $ALNY https://t.co/yND1GzsbqA
September 23rd 2017, 4:09am
emq_news @emq_news
Alnylam Pharmaceuticals Target of Unusually Large Options Trading $ALNY https://t.co/mvdJRsHRK7
September 23rd 2017, 4:09am
TheMarketsDaily @TheMarketsDaily
Alnylam Pharmaceuticals, Inc. $ALNY Stock Rating Reaffirmed by Ladenburg Thalmann Financial Services https://t.co/EqrvXKkw0m
September 23rd 2017, 2:09am
dailymailtimes @dailymailtimes
Alnylam Pharmaceuticals Target of Unusually High Options Trading $ALNY https://t.co/AOFYdQx1F3
September 23rd 2017, 1:09am
dakotafinancial @dakotafinancial
Alnylam Pharmaceuticals, Inc. $ALNY Sees Unusually-High Trading Volume After Analyst Upgrade https://t.co/lu9erbthJ9
September 23rd 2017, 1:09am
CFinancialNews @CFinancialNews
Alnylam Pharmaceuticals Target of Unusually High Options Trading $ALNY https://t.co/SAkAU4vHK7
September 23rd 2017, 1:09am
WKRBNews @WKRBNews
Alnylam Pharmaceuticals Target of Unusually High Options Trading $ALNY https://t.co/tNw33vOksh
September 23rd 2017, 1:09am
intercooleronli @intercooleronli
Alnylam Pharmaceuticals Target of Unusually High Options Trading $ALNY https://t.co/LbcanamOAO
September 23rd 2017, 1:09am
midetimes @midetimes
Alnylam Pharmaceuticals Target of Unusually High Options Trading $ALNY https://t.co/D3xHM5Wkay
September 23rd 2017, 1:09am
dailypoliticaln @dailypoliticaln
Alnylam Pharmaceuticals Target of Unusually High Options Trading $ALNY https://t.co/64WSVc7O9Q
September 23rd 2017, 1:09am
dakotafinancial @dakotafinancial
Alnylam Pharmaceuticals, Inc. $ALNY Sets New 52-Week High on Analyst Upgrade https://t.co/jqAb1cyjck
September 23rd 2017, 12:09am
intercooleronli @intercooleronli
Insider Selling: Alnylam Pharmaceuticals, Inc. $ALNY President Sells 76,815 Shares of Stock https://t.co/SrRARGIO1o
September 22nd 2017, 7:09pm
measured_moves @measured_moves
@RobInTheBlack Clearly you skipped over $IZEA and $ALNY. But yeah, go ahead kid
September 22nd 2017, 7:09pm
SleekMoneycom @SleekMoneycom
Insider Selling: Alnylam Pharmaceuticals, Inc. $ALNY President Sells 76,815 Shares of Stock https://t.co/AqvzsXEio5
September 22nd 2017, 7:09pm
CFinancialNews @CFinancialNews
Insider Selling: Alnylam Pharmaceuticals, Inc. $ALNY President Sells 76,815 Shares of Stock https://t.co/5NFpeCxerR
September 22nd 2017, 7:09pm
IonisDisrupts @IonisDisrupts
@US_FDA @JohnCendpts It's the #Biotech version of bait and switch. And how does $ALNY get away calling 20 mgs of De… https://t.co/FaBy3tLDnF
September 22nd 2017, 6:09pm
IonisDisrupts @IonisDisrupts
@MaisaCorp Aka more greater fools out there $ALNY
September 22nd 2017, 5:09pm
InsiderAlertsIA @InsiderAlertsIA
$ALNY: New Insider Filing on President BARRY E GREENE: https://t.co/9rwuTY6r4U
September 22nd 2017, 5:09pm
MaxPirateHero @MaxPirateHero
Case Study $ALNY Day 3 Continuation Play. This is the play I wish I had done (I KNEW it would rally!) instead of lo… https://t.co/MM9DW11gUk
September 22nd 2017, 4:09pm
IonisDisrupts @IonisDisrupts
@US_FDA @JohnCendpts $ALNY not listing steroids in Apollo. If I were #amyloidosis sufferer I would want 2 know! Esp… https://t.co/UY3GHHFdQB
September 22nd 2017, 4:09pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.